Cargando…
The Role of BRAF in Metastatic Colorectal Carcinoma–Past, Present, and Future
With a global incidence of 1.8 million cases, colorectal cancer represents one of the most common cancers worldwide. Despite impressive improvements in treatment efficacy through cytotoxic and biological agents, the cancer-related death burden of metastatic colorectal cancer (mCRC) is still high. mC...
Autores principales: | Djanani, Angela, Eller, Silvia, Öfner, Dietmar, Troppmair, Jakob, Maglione, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729567/ https://www.ncbi.nlm.nih.gov/pubmed/33256240 http://dx.doi.org/10.3390/ijms21239001 |
Ejemplares similares
-
BRAF-mutated metastatic colorectal cancer between past and future
por: Cremolini, Chiara, et al.
Publicado: (2015) -
Targeting Oncogenic BRAF: Past, Present, and Future
por: Zaman, Aubhishek, et al.
Publicado: (2019) -
Associations of Oxidative Stress and Postoperative Outcome in Liver Surgery with an Outlook to Future Potential Therapeutic Options
por: Senoner, Thomas, et al.
Publicado: (2019) -
Therapy for metastatic melanoma: the past, present, and future
por: Finn, Laura, et al.
Publicado: (2012) -
Progressive Oncological Surgery Is Associated with Increased Curative Resection Rates and Improved Survival in Metastatic Colorectal Cancer
por: Primavesi, Florian, et al.
Publicado: (2019)